Chronic Kidney Disease News

A kidney failure risk equation model had acceptable discrimination and calibration, and “better clinical utility” than an eGFR-based strategy to assess kidney failure rates in Chinese patients, according to a study in Kidney Medicine.

Patients with chronic kidney disease have limited opportunities to engage in shared-decision-making with their physicians, according to a published Danish study.

The autosomal dominant polycystic kidney disease registry may help assess various aspects of disease burden on patients’ health-related quality of life, according to published research.

The FDA has granted orphan drug designation to AP303 for the treatment of autosomal dominant polycystic kidney disease.

Intensive lifestyle intervention did not significantly change eGFR slope during 10 years in patients with type 2 diabetes and preserved kidney function, researchers found in a study.

Calyxo Inc. has received FDA approval for a device that sweeps up kidney stone fragments after laser lithotripsy, according to a company press release.

Preventive pharmacological therapy may help to reduce reoccurring symptoms in patients with urolithiasis and hypercalciuria, according to data from a retrospective cohort study.

Geriatric assessment may be successfully applied to chronic kidney disease care for patients older than 70 years, and health care providers perceive it as relevant and beneficial, data show.

Adults with diabetes who are forced to switch to a high-deductible health insurance plan have higher risk for diabetes-related complications than those who remain on a regular health plan, according to study data.

Deprescribing through clinical decision support along with providing safety brochures may be an effective method to address potentially inappropriate medications for patients on dialysis.